Induction of apoptosis and inhibition of cell growth are independent responses to interferon-α in hematopoietic cell lines

Cell Growth and Differentiation

Volumn 8, Issue 3, 1997, Pages 343-352

  Sangfelt, Olle ^a   Erickson, Sven ^a   Castro, Juan ^a   Heiden, Thomas ^a   Einhorn, Stefan ^a   Grandér, Dan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; DAUDI CELL; DNA DEGRADATION; FLOW CYTOMETRY; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BROMODEOXYURIDINE; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; DNA; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-ALPHA; MICROSCOPY, FLUORESCENCE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030916238     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schindler, C., and Darnell, J. E., Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem., 64: 621-651, 1995.
2. De Mayer, E., and De Mayer-Guignard, J. Interferons and Other Regulatory Cytokines. New York: John Wiley & Sons, Inc., 1988.
3. Einhorn, S., and Strander, H. Interferon treatment of human malignancies: a short review. Med. Oncol. Tumor Pharmacother., 10: 25-29, 1993.
4. Grandér, D., Xu, B., and Einhorn, S. Cytotoxic effect of interferon on primary malignant tumor cells. Studies in various malignancies. Eur. J. Cancer, 14: 1940-1943, 1993.
5. Manabe, A., Yi, T., Kumagai, M., and Campana, D. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon α in acute lymphoblastic leukemia. Leukemia (Baltimore), 7: 1990-1995, 1993.
6. Deiss, L. P., Feinstein, E., Berissi, H., Cohen, O., and Kimchi, A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ-interferon-induced cell death. Genes & Dev., 9: 15-30, 1995.
7. Trubiani, O., Bosco, D., and Di-Primio, R. Interferon-γ (IFN-γ) induces programmed cell death in differentiated human leukemic B-cell lines. Exp. Cell Res., 215: 23-27, 1994.
8. Rodríguez-Villanueva, J., and McDonnell, T. J. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α. Int. J. Cancer, 61: 110-114, 1995.
9. Sangfelt, O., Einhorn, S., Björklund, A. C., Wiman, K. G., Okan, I., and Grandér, D. Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon-γ. Int. J. Cancer, 67: 106-112, 1996.
10. Milner, A. E., Grand, R. J. A., and Gregory, C. D. Effects of interferon-α on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines. Int. J. Cancer, 61: 348-354, 1995.
11. Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K. L., Giles, F. J., and Goldstone, A. H. Interferon-α up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br. J. Haematol., 88: 268-274, 1994.
12. Kimchi, A. Cytokine-triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem., 50: 1-9, 1992.
13. Evans, D. L., and Mansel, R. E. Molecular evolution and secondary structural conservation in the B-cell lymphoma leukemia 2 (bcl-2) family of proto-oncogene products. J. Mol. Evol., 41: 775-783, 1995.
14. Nicholson, D. W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol., 14: 297-301, 1996.
15. Baker, S. J., and Reddy, E. P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12: 1-9, 1996.
16. Haupt, Y., Rowan, S., and Oren, M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10: 1563-1571, 1995.
17. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y-K., and Israel, M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14: 461-472, 1995.
18. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
19. Wu, X., and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 97: 3602-3606, 1994.
20. Cowling, G. J., and Dexter, T. M. Apoptosis in the hematopoietic system. Philos. Trans. R. Soc. Lond. B Biol. Sci., 345: 257-263, 1994.
21. Taylor-Papadimitriou, J., and Rozengurt, E. Interferons as regulators of cell growth and differentiation. In: J. Taylor-Papadimitriou (ed.), Interferons, Their Impact In Biology And Medicine, p. 81. Oxford, United Kingdom: Oxford Medical Publications, 1985.
22. Resnitzky, D., Tiefenbrun, H. B., and Kimchi, A. Interferons and interleukins 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
23. Darzynkiewicz, Z., Brunao, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
24. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993.
25. Evan, G. I., Brown, L., Whyte, M., and Harrington, E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol., 7: 825-834, 1995.
26. Jernberg-Wiklund, H., Pettersson, M., Larsson, L. G., Anton, R., and Nilsson, K. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line. Int. J. Cancer, 51: 116-123, 1992.
27. Wiman, K. G., Magnusson, K. P., Ramqvist, T., and Klein, G. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody Pab240. Oncogene, 6: 1633-1639, 1991.
28. Mazars, G. R., Portier, M., Zhang, X. G., Jourdan, M., Bataille, R., Theillet, C., and Klein, B. Mutations of the p53 gene in human myeloma cell lines. Oncogene, 7: 1015-1018, 1992.
29. Cheng, J., and Haas, M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol., 10: 5502-5509, 1990.
30. Stanbridge, E. J., and Nowell, P. C. Origins of human cancer revisited. Cell, 63: 867-874, 1990.
31. Donehower, L. A., and Bradley, A. The tumor suppressor p53. Biochim. Biophys. Acta, 1155: 181-205, 1993.
32. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
33. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
34. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
35. Miyashita, T., Krajewski, S., Krajewski, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
36. Moberg, K. H., Tyndall, W. A., and Hall, D. J. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell. Biochem., 49: 208-215, 1992.
37. Liebermann, D. A., Hoffman, B., and Steinman, R. A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene, 11: 199-210, 1995.
38. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., and Taniguchi, T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376: 596-599, 1995.
39. Sangfelt, O., Österborg, A., Grandér, D., Anderbring, E., Öst, Å., Mellstedt, H., and Einhorn, S. Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein. Int. J. Cancer, 63: 190-192, 1995.
40. Mann, D. Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res. Hum. Retroviruses, 5: 253-255, 1989.
41. Castro, J., Heiden, T., Wang, N., and Tribukait, B. Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry, 14: 793-804, 1993.
42. Beisker, W., Dolbeare, F., and Gray, J. W. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Cytometry, 8: 235-239, 1987.
43. Heiden, T., Gohde, W., and Tribukait, B. Two-wavelength mercury arc lamp excitation for flow cytometric DNA-protein analyses. Anticancer Res., 10: 1555-1562, 1990.
44. Ramqvist, T., Magnusson, K. P., Wang, Y., Szekely, L., Klein, G., and Wiman, K. G. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) cell line that carries mutant p53. Oncogene, 8: 1495-1500, 1993.
45. Heyman, M., Grandér, D., Bröndum-Nielsen, K., Cederblad, B., Liu, Y., Xu, B., and Einhorn, S. Interferon system defects in malignant T-cells. Leukemia (Baltimore), 8: 425-434, 1994.